Published in Blood Weekly, February 1st, 2001
"Warfarin is a 4-hydroxycoumarin anticoagulant drug used for the prevention and management of thromboembolic and vascular diseases," A.C. Falcao and colleagues at the University of Coimbra explained in the Journal of Pharmacy and Pharmacology. "Appropriate use of warfarin requires patient monitoring and dosage adjustments, to ensure its safety and efficacy."
Traditionally, warfarin response has been evaluated using prothrombin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2001-02-01)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.